UroMems
Latest round
- Series C
Last raised
- Jun 2024
Total raised
- $75M
Investors
- 11
About UroMems
Based in France, SAS UroMems specializes in advanced medical devices focused on treating severe stress urinary incontinence (SUI) through innovative implantable technology. SAS UroMems, founded in 2011 in Grenoble, France, develops medical technology aimed at addressing urinary incontinence. The co-founders, Hamid LAMRAOUI (CEO), Pierre Mozer and Stephane Lavallee, have established the company as a significant player in the field. UroMems focuses on developing advanced medical technologies, specifically its flagship product, UroActive™, which addresses severe stress urinary incontinence (SUI) for both genders. The implantable device is engineered to adapt automatically to individual patient needs, enhancing their quality of life.00, indicating a focus on product development rather than sales at this stage. The company’s revenue model relies on partnerships with healthcare providers and clinical institutions, where revenues are expected to arise from UroActive™ sales as they progress through clinical stages and reach commercialization.
Who invested in UroMems
11 investors across 4 rounds
See all investors in UroMems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about UroMems
Who invested in UroMems?
UroMems has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has UroMems raised?
UroMems has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did UroMems last raise money?
UroMems's most recent round on record is a Series C, in Jun 2024.
What does UroMems do?
Based in France, SAS UroMems specializes in advanced medical devices focused on treating severe stress urinary incontinence (SUI) through innovative implantable technology.
Where is UroMems headquartered?
UroMems is headquartered in Grenoble, France.
Which VCs invest in companies like UroMems?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at UroMems's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like UroMems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.